Last reviewed · How we verify
GCJBP Laennec Inj.
GCJBP Laennec is a human placenta extract injection that provides nutritional and regenerative support through bioactive components derived from placental tissue.
GCJBP Laennec is a human placenta extract injection that provides nutritional and regenerative support through bioactive components derived from placental tissue. Used for Tissue repair and regeneration support, Post-operative recovery, Chronic liver disease (investigational).
At a glance
| Generic name | GCJBP Laennec Inj. |
|---|---|
| Also known as | Human placenta hydrolysate |
| Sponsor | Ho Cheol Shin, M.D., Ph.D. |
| Drug class | Placental extract |
| Modality | Small molecule |
| Therapeutic area | Regenerative Medicine / General Health |
| Phase | Phase 3 |
Mechanism of action
Laennec is a standardized human placental extract containing amino acids, nucleotides, growth factors, and other bioactive molecules. It is administered via injection to support tissue repair, immune function, and metabolic processes. The mechanism is thought to involve provision of essential nutrients and growth-promoting factors that facilitate cellular regeneration and recovery.
Approved indications
- Tissue repair and regeneration support
- Post-operative recovery
- Chronic liver disease (investigational)
Common side effects
- Injection site reactions
- Allergic reactions
- Fever
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |